These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 11983802)

  • 1. Risk factors for treatment-resistive methamphetamine psychosis.
    Fujii D
    J Neuropsychiatry Clin Neurosci; 2002; 14(2):239-40. PubMed ID: 11983802
    [No Abstract]   [Full Text] [Related]  

  • 2. Olanzapine treatment of methamphetamine psychosis.
    Misra LK; Kofoed L; Oesterheld JR; Richards GA
    J Clin Psychopharmacol; 2000 Jun; 20(3):393-4. PubMed ID: 10831035
    [No Abstract]   [Full Text] [Related]  

  • 3. Remission of persistent methamphetamine-induced psychosis after electroconvulsive therapy: presentation of a case and review of the literature.
    Grelotti DJ; Kanayama G; Pope HG
    Am J Psychiatry; 2010 Jan; 167(1):17-23. PubMed ID: 20068123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Drug-induced psychosis associated with crystalline methamphetamine.
    Dore G; Sweeting M
    Australas Psychiatry; 2006 Mar; 14(1):86-9. PubMed ID: 16630206
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Amphetamine-induced psychosis or schizophrenia?].
    Rognli EB; Medhus SE; Bramness JG
    Tidsskr Nor Laegeforen; 2015 Feb; 135(3):249-51. PubMed ID: 25668544
    [No Abstract]   [Full Text] [Related]  

  • 6. Risperidone treatment of amphetamine psychosis.
    Jha A; Fourie H
    Br J Psychiatry; 1999 Apr; 174():366. PubMed ID: 10533557
    [No Abstract]   [Full Text] [Related]  

  • 7. First psychotic episode risk markers for primary psychosis amongst people who use methamphetamine.
    McKetin R; Hides L; Kavanagh DJ; Saunders JB; Dawe S
    Schizophr Res; 2018 Sep; 199():456-457. PubMed ID: 29680188
    [No Abstract]   [Full Text] [Related]  

  • 8. Methamphetamine-associated psychosis: links to drug use characteristics and similarity to primary psychosis.
    Yang M; Yang C; Liu T; London ED
    Int J Psychiatry Clin Pract; 2020 Mar; 24(1):31-37. PubMed ID: 31609149
    [No Abstract]   [Full Text] [Related]  

  • 9. [Molecular mechanism for methamphetamine-induced memory impairment].
    Nagai T; Yamada K
    Nihon Arukoru Yakubutsu Igakkai Zasshi; 2010 Apr; 45(2):81-91. PubMed ID: 20486560
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Susceptibility to subsequent episodes in spontaneous recurrence of methamphetamine psychosis.
    Yui K; Ishiguro T; Goto K; Ikemoto S
    Ann N Y Acad Sci; 2000 Sep; 914():292-302. PubMed ID: 11085329
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Methamphetamine: drug use and psychoses becomes a major public health issue in the Asia Pacific region.
    Farrell M; Marsden J; Ali R; Ling W
    Addiction; 2002 Jul; 97(7):771-2. PubMed ID: 12133111
    [No Abstract]   [Full Text] [Related]  

  • 12. Reaction time variability and related brain activity in methamphetamine psychosis.
    Fassbender C; Lesh TA; Ursu S; Salo R
    Biol Psychiatry; 2015 Mar; 77(5):465-74. PubMed ID: 25444164
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Vigilance needed with methamphetamine-associated psychosis.
    Elefante RJO; Nolan S; Bach PJ
    CMAJ; 2023 Oct; 195(39):E1356. PubMed ID: 37816525
    [No Abstract]   [Full Text] [Related]  

  • 14. Methamphetamine-Induced Psychosis and Schizophrenia: A Call for Special Attention.
    Zhu L; Ni T; Guan F
    Am J Psychiatry; 2024 Feb; 181(2):168. PubMed ID: 38298079
    [No Abstract]   [Full Text] [Related]  

  • 15. Characterizing prefrontal cortical activity during inhibition task in methamphetamine-associated psychosis versus schizophrenia: a multi-channel near-infrared spectroscopy study.
    Okada N; Takahashi K; Nishimura Y; Koike S; Ishii-Takahashi A; Sakakibara E; Satomura Y; Kinoshita A; Takizawa R; Kawasaki S; Nakakita M; Ohtani T; Okazaki Y; Kasai K
    Addict Biol; 2016 Mar; 21(2):489-503. PubMed ID: 25619621
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Stress induced spontaneous recurrence of methamphetamine psychosis: the relation between stressful experiences and sensitivity to stress.
    Yui K; Goto K; Ikemoto S; Ishiguro T
    Drug Alcohol Depend; 2000 Feb; 58(1-2):67-75. PubMed ID: 10669056
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Increased sensitivity to stress in spontaneous recurrence of methamphetamine psychosis: noradrenergic hyperactivity with contribution from dopaminergic hyperactivity.
    Yui K; Goto K; Ikemoto S; Ishiguro T; Kamata Y
    J Clin Psychopharmacol; 2000 Apr; 20(2):165-74. PubMed ID: 10770454
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Psychostimulant use and the brain.
    Lappin JM; Sara GE
    Addiction; 2019 Nov; 114(11):2065-2077. PubMed ID: 31321819
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Psychosis associated with switching from risperidone to aripiprazole in an adolescent on methylphenidate treatment.
    Ekinci O; Sabuncuoglu O
    Prog Neuropsychopharmacol Biol Psychiatry; 2011 Mar; 35(2):648-9. PubMed ID: 21134409
    [No Abstract]   [Full Text] [Related]  

  • 20. Risperidone treatment of methamphetamine psychosis.
    Misra L; Kofoed L
    Am J Psychiatry; 1997 Aug; 154(8):1170. PubMed ID: 9247413
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 8.